Stay updated on Pembrolizumab + Bevacizumab in Recurrent GBM Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab + Bevacizumab in Recurrent GBM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab + Bevacizumab in Recurrent GBM Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The footer revision label was updated from v3.5.3 to v3.5.4, indicating a small build/version update.
    Difference
    0.1%
    Check dated 2026-05-16T09:30:01.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    42 days ago
    Change Detected
    Summary
    The page’s revision/version indicator has been updated from v3.5.2 to v3.5.3, reflecting a site software update rather than a change to the clinical trial information.
    Difference
    0.1%
    Check dated 2026-04-24T22:19:48.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T14:09:11.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    Revision history updated: added Revision: v3.5.0; removed Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T23:50:34.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    Updated the site revision tag to v3.4.3 and removed the previous v3.4.2 reference.
    Difference
    0.1%
    Check dated 2026-03-12T20:29:48.000Z thumbnail image
  9. Check
    114 days ago
    Change Detected
    Summary
    Revision history updated: added v3.4.2 and removed v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-12T02:44:38.000Z thumbnail image

Stay in the know with updates to Pembrolizumab + Bevacizumab in Recurrent GBM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Bevacizumab in Recurrent GBM Clinical Trial page.